Home › Funds › EULAV Asset Management › EXEL
EULAV Asset Management position in EXEL
EXELIXIS INC · Health Care
EULAV Asset Management reported holding 432,060 shares of EXEL (EXELIXIS INC) in its Q3 2026 13F filing — a position valued at US$25.2M, representing 0.91% of its reported portfolio and ranking #40 among its reported holdings. EULAV Asset Management has disclosed EXEL holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How EULAV Asset Management's EXEL position evolved
EULAV Asset Management first disclosed a stake in EXEL in Q3 2023 at 650,000 shares (US$14.2M). The position peaked in Q2 2025 at 595,067 shares, worth US$26.2M. Across 13 filings, EULAV Asset Management increased the stake 2 time(s), trimmed it 9 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 432,060 shares valued at US$25.2M — a reduction of -43,983 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 650.00K | $14.20M | New |
| Q4 2023 | 650.00K | $15.59M | Hold |
| Q1 2024 | 610.00K | $14.48M | Reduce |
| Q2 2024 | 545.00K | $12.25M | Reduce |
| Q3 2024 | 500.00K | $12.97M | Reduce |
| Q4 2024 | 480.00K | $15.98M | Reduce |
| Q1 2025 | 530.00K | $19.57M | Add |
| Q2 2025 | 595.07K | $26.23M | Add |
| Q3 2025 | 570.05K | $23.54M | Reduce |
| Q4 2025 | 535.04K | $23.45M | Reduce |
| Q1 2026 | 492.04K | $21.10M | Reduce |
| Q2 2026 | 476.04K | $25.90M | Reduce |
| Q3 2026 | 432.06K | $25.24M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About EXEL and 13F data
EXEL (EXELIXIS INC) is a Health Care company. 41 other funds we track also report a position in EXEL — the largest reported positions include Renaissance Technologies (US$747.2M), Farallon Capital Management (US$732.8M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$732.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding EXEL
- Renaissance Technologies 12.79M sh · $747.22M · Q3 2026
- Farallon Capital Management 13.47M sh · $732.79M · Q2 2026
- FARALLON CAPITAL MANAGEMENT, L.L.C. 13.47M sh · $732.79M · Q2 2026
- FULLER & THALER ASSET MANAGEMENT, INC. 8.93M sh · $485.85M · Q2 2026
- D. E. Shaw & Co., Inc. 5.55M sh · $302.07M · Q2 2026
- Two Sigma Investments 4.21M sh · $229.06M · Q2 2026
- Stephens Investment Management Group LLC 2.60M sh · $151.65M · Q3 2026
- Caligan Partners LP 1.55M sh · $84.51M · Q2 2026
More on EULAV Asset Management
FAQ
How long has EULAV Asset Management held EXEL?
EULAV Asset Management has disclosed EXEL holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is EULAV Asset Management's current position in EXEL?
As of Q3 2026, EULAV Asset Management holds 432.06K shares of EXEL (EXELIXIS INC), valued at $25.24M, representing 0.91% of its reported portfolio and ranking #40.
Has EULAV Asset Management been buying or selling EXEL?
In the latest 13F filing (Q3 2026), EULAV Asset Management reduced its position in EXEL. The position peaked in Q2 2025 at 595.07K shares.
Which other funds hold EXEL?
Other major institutional holders of EXEL include Renaissance Technologies, Farallon Capital Management, FARALLON CAPITAL MANAGEMENT, L.L.C., among 41 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.